National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 10/29/2007     First Published: 10/1/1997  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
Related Links
Educational Materials About Clinical Trials

Clinical Trials

Questions to Ask Your Doctor

Drug Information from MedlinePlus
Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase II Study of Carbon Dioxide Laser Surgery and Radiation Therapy in Stage I, II, and Selected Stage III Squamous Cell Carcinoma of the Supraglottic Larynx

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentClosedOver 18NCISWOG-S9709
NCT00003040, S9709

Trial Description

Purpose:

Laser surgery for cancer of the larynx may have fewer side effects and improve recovery. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy and laser surgery may kill more tumor cells.

Phase II trial to study the effectiveness of laser surgery plus radiation therapy in treating patients with early stage cancer of the larynx.

Eligibility:

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Within 4 weeks of registration, patients will undergo laser surgery followed 2 weeks later by radiation therapy. Some patients may undergo surgery to remove lymph nodes in the neck. Patients will receive follow-up evaluations every 3 months for 1 year, every 6 months for 1 year, and once a year thereafter.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Southwest Oncology Group

Roy Davis, MD, Protocol chair(Contact information may not be current)
Ph: 801-585-0303; 877-585-0303

Registry Information
Official Title A Phase II Study to Evaluate Transoral CO2 Laser Supraglottic Laryngectomy and Irradiation in Stage I, II and III Squamous Cell Carcinoma of the Supraglottic Larynx
Trial Start Date 1997-09-15
Registered in ClinicalTrials.gov NCT00003040
Date Submitted to PDQ 1997-08-18
Information Last Verified 2007-10-29
NCI Grant/Contract Number CA32102

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov